期刊文献+

不同时期应用甲状旁腺激素片段对糖皮质激素相关骨质疏松的影响 被引量:1

The effect of the application of parathyroid hormone 1-34 in different phase on glucocoticoid-induced osteoporosis
下载PDF
导出
摘要 目的了解早期应用重组人甲状旁腺激素片段1-34与延迟应用对糖皮质激素诱导的骨质疏松是否存在着不同。方法选用36只日本大耳白兔,分为3个组,其中A组做为空白对照组,不施加任何处理因素,B组为早期干预组,C组为延迟干预组。B组和C组首先在4周内注射马血清10 mg/kg两次,自第5周开始每天注射一次地塞米松,第6至第9周每周注射2次地塞米松,剂量均为10mg/kg,B组从第5周开始使用地塞米松时同时给予重组人甲状旁腺激素片段1-34,20μg/天至第12周;C组第9周开始应用直到第16周,B组第12周、C组第16周处死动物,取第三腰椎进行骨形态学及DXA骨密度检查,采用photoshop软件分析骨小梁面积占整个图像面积百分比。结果骨形态学检查A组骨小梁结构最好,骨小梁占整个图像百分比为16.50%,B组次之,为8.21%,C组最差,为4.5%,3组间的差异存在着统计学意义,而骨密度检查在3组间没有差别。结论 与不使用糖皮质激素相比,早期使用和延迟应用甲状旁腺激素都可以延缓骨矿含量的流失,早期使用效果更好,但是不能完全阻止这种流失。 Objective To study the difference between the early and late intervention with parathyroid hormone (PTH) 1-34 for the treatment of glucocoid-induce osteoporosis. Methods Thirty-six Japanese rabbits were divided into 3 groups. Group A was normal control without any intervention. Group B was early intervention group. Group C was late intervention group. Rabbits in the group B and C were injected twice with horse serum in the first 4 weeks, and followed by dexamethasone (10 mg/kg) injection daily on the fifth week and twice a week from the sixth week to the eighth week. PTH 1-34 (20μg/d) was injected to the rabbits of group B daily from the sixth week to the twelfth week, and group C from the ninth week to the sixteenth week. Rabbits in Group B and C were sacrificed on the twelfth week and sixteenth week, respectively. The lumbar vertebrae 3 was used for bone histomorphometry and bone mineral density examination. The percentage of bone trabecular area to the whole image area was calculated using the Photoshop software. Results The best trabecular construction was found in group A in the bone histomorphometry examination. The percentage of trabecular area of the whole image was 16.50% in group A, 8.21% in group B, and 4.50% in group C. There were statistic differences among the 3 groups. No differences among the 3 groups were found in terms of bone mineral density. Conclusion Compared to no application of glucocoticoid hormone, either early or late intervention with PTH shows prevention from mineral loss. Early intervention produces better result. However, bone loss can not be prevented completely.
机构地区 天津医院干部科
出处 《中国骨质疏松杂志》 CAS CSCD 2010年第12期924-926,919,共4页 Chinese Journal of Osteoporosis
关键词 甲状旁腺激素 糖皮质激素 骨质疏松 干预 Parathyroid hormone Glucocorticoid Osteoporosis Intervention
  • 相关文献

参考文献10

  • 1李子荣,张念非,岳德波,杨连发,张惠铭,张秉均,郑剑辉.激素性股骨头坏死动物模型的诱导和观察[J].中华外科杂志,1995,33(8):485-487. 被引量:83
  • 2Hong D, Chen HX, Xue Y, et al. Osteoblastogenie effects of dexamethasone through upregulation of TAZ expression in rat mesenehymal stem cells. J Steroid Biochem Mol Biol, 2009, 116 (1-2) : 86-92.
  • 3Weiustein RS, Jilka RL, Almeida M, et al. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology, 2010, 151 (6) : 2641-2649.
  • 4Scholz-Ahrens KE, Delling G, Stampa B, et al. Glucocorticosteroid-induced osteoporosis in aduh primiparous Gottingen miniature pigs: effects on bone mineral and mineral metabolism. Am J Physiol Endoerinol Metab, 2007, 293: 385- 395.
  • 5Brixen KT, Christensen B, Ejersted C, et al. Teriparatide ( biosynthetic human parathyroid hormone 1-34 ) : a new paradigm in the treatment of osteoporosis. Basic Clin Pharmacol Toxicol, 2004,94 (4) :260-270.
  • 6Glover SJ, Eastell R, McCloskey EV, et al. Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. Bone, 2009,45 (6) : 1053-1058.
  • 7Oxlund H, Ortoft G, Thomsen JS, et al. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment. Bone, 2006, (39) :244-252.
  • 8Postnov A, De Schutter T, Sijbers J, et al. Glucocorticoid- induced osteoporosis in growing mice is not prevented by simultaneous intermittent PTH treatment. Calcif Tissue Int, 2009,85 (6) :530-537.
  • 9邹锦慧,李景田,张慧明,何文英,周小璜,李伯灵.甲状旁腺素和二膦酸盐对激素性骨质疏松影响的超微结构观察[J].四川解剖学杂志,2006,14(2):11-14. 被引量:2
  • 10邹锦慧,李景田,何文英,张慧明,周小璜,李伯灵,李沐吉.甲状旁腺素和二膦酸盐对骨密度和骨生物力学的影响[J].解剖学杂志,2006,29(3):332-335. 被引量:3

二级参考文献22

  • 1李梅,矫杰,孟迅吾,邢小平,夏维波,周学瀛,刘怀成,姜艳,王鸥,胡莹莹,詹志伟.甲状旁腺素片段与阿仑膦酸钠对骨质疏松大鼠骨转换和骨密度的影响[J].中华医学杂志,2005,85(5):335-338. 被引量:10
  • 2胡侦明,戴克戎.卵巢切除对鼠椎体骨形态学的影响[J].中国骨质疏松杂志,1998,4(4):9-12. 被引量:4
  • 3廖进民,李青南,黄莲芳,谢华,刘郴淑.泼尼松对大鼠骨骼影响的实验研究[J].解剖学杂志,1994,17(4):358-360. 被引量:21
  • 4Jones J P,中华骨科杂志,1994年,14卷,153页
  • 5王金熙,中华外科杂志,1993年,31卷,374页
  • 6李子荣,中日友好医院学报,1992年,6卷,187页
  • 7Ukert BP, Raise LG. Glucocorticoi dinduced osteoporosis: Pathogenesis and management. Ann Intern Med, 1990, 112 (5): 352-364
  • 8Silvestrine G, Ballanti P, Patacchioli FR, et al. Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth pate and metaphyseal one cells of rats after highdose treatment with corticosterone, Bone, 2000,26(1):33-42
  • 9Brixen KT, Christensen B, Ejersted C, et al. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Basic Clin Pharmacol Toxicol, 2004,94(4): 260-270.
  • 10Delmas PD. Treatment of postmenopausal osteoporosis. Lancet,2002,359(14):2018-2026

共引文献85

同被引文献45

  • 1卢立肖,张宇,庄捷秋,杨青,林瑞霞,张颖.糖皮质激素对肾病综合征患儿骨代谢的影响[J].实用儿科临床杂志,2006,21(8):475-476. 被引量:21
  • 2邹世恩,张绍芬.雌激素对成骨细胞和破骨细胞凋亡的调节机制[J].现代妇产科进展,2006,15(7):547-548. 被引量:18
  • 3贾少杰,贾晓静.雌激素抗骨质疏松的OPG/RANKL和ApoE作用机制的实验研究[J].中国老年学杂志,2007,27(23):2274-2276. 被引量:6
  • 4Giustina A, Mazziotti G, Canalis E, et al. Growth hormone, insulin- like growth factors, and the skeleton [J ]. Endocr Rev, 2008,29 ( 5 ) : 535-559. DOI . 10. 1210/er. 2007-0036.
  • 5Donatti TL, Koch VH, Takayama L, et al. Effects of glucocorticoids on growth and bone mineralization [ J ]. J Pediatr ( Rio J ) , 2011,87 ( 1 ) ,4-12. DOI: 10.2223/JPED. 2052.
  • 6Leal-Cerro A, Soto A, Martfnez MA, et al. Effects of withdrawal of somatostatin plus growth hormone (GH) -releasing hormone as a sti- miulus of GH secretion in Cushing's Syndrome [ J ]. Clin Endocrinol (Oxf) 2002,57(6) :745-749.
  • 7Deshmukh CT. Minimizing side effects of systemic corticosteroids in children [ J ] Indian J Dermatol Venereol Leprol, 2007,73 ( 4 ) : 218-221.
  • 8Feber J, Gaboury I, Ni A, et al. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome [J]. Osteoporos Int,2012,23 (2) :751-760. DOI: 10. 1007/s00198- 011-1621-2.
  • 9Kosan C, Ayar G, Orbak Z. Effects of steroid treatment on bone min- eral metabolism in children with glucocorticoid-sensifive nephrotic syndrome[J]. West Indian Med J,2012,61 (6) :627-630.
  • 10van Staa TP, Cooper C, Leufkens HG, et al. Use of oral corticoste- roids and risk of fractures [J]. J Bone Miner Res, 2003,18 ( 5 ) : 913-918.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部